Selected Presentations by NCI Acting Director Dr. Douglas Lowy
NCI Principal Deputy Director Douglas Lowy speaks at a meeting of the National Cancer Advisory Board.
Dr. Douglas R. Lowy delivers updates to NCI advisory boards and a variety of talks and briefings to the cancer community about strategic and scientific initiatives to advance cancer research and care.
NCI Advisory Board Presentations
A Perspective on the FY22 NCI Budget Appropriation
Board Of Scientific Advisors, March 28, 2022
NCI/DOE Collaboration
Frederick National Laboratory Advisory Committee, February 24, 2022
Allocation of NCI Appropriated Dollars for Research
Virtual National Cancer Advisory Board Meeting, September 1, 2021
NCI/DOE Collaboration — Implementation of NCI/DOE Collaboration Task Force Recommendations
Frederick National Laboratory Advisory Committee, June 28, 2021
NCI Serology Studies
NCI Council of Research Advocates, July 16, 2020
COVID-19 Research Initiatives at the Frederick National Laboratory
Virtual Meeting of the Frederick National Laboratory Advisory Committee, July 13, 2020
Update: COVID-19 Serology and Immunology Capacity Building
Virtual Meeting of the National Cancer Advisory Board and the Board of Scientific Advisors, June 15, 2020
Serology and Immunology Capacity Building
Virtual Meeting of the Frederick National Laboratory Advisory Committee, May 21, 2020
NCI Deputy Director's Report
Virtual Joint Meeting of NCI Board of Scientific Advisors & National Cancer Advisory Board, April 9, 2020
A Closer Look at the NCI Budget and RPG Pool
Joint Meeting of the National Cancer Advisory Board & Board of Scientific Advisors, December 3, 2019
NCI Director's Update
Frederick National Laboratory Advisory Committee, October 24, 2019
NCI Director's Update (slides, video)
National Cancer Advisory Board, September 4, 2019
NCI Director's Update
Clinical Trials and Translational Research Advisory Committee, July 17, 2019
NCI Director's Update
Frederick National Laboratory Advisory Committee, June 27, 2019
NCI Director's Update
RPG Pool Analysis
National Cancer Advisory Board & Board of Scientific Advisors, June 11, 2019
All Other NCI Presentations
Cancer Research Opportunities Funding and Progress
American Society of Clinical Oncology Annual Meeting, June 10, 2022
Equity in the Healthcare Workforce: Why it Matters for Patients
NCI Social Media Panel Discussion, June 9, 2022
Research Progress, Funding, and Opportunities: A Fireside Chat – Slides and audio only
American Association for Cancer Research Annual Meeting, April 11, 2022
The Molecular Basis of HPV–associated Cancers Underlies the HPV Vaccine and Today’s Cervical Cancer Screening
American Society of Dermatopathology Virtual Annual Meeting, October 23, 2021
Current and Future Impact of the HPV Vaccine
American Urological Association Conference, September 12, 2021
HPV Vaccination to Prevent HPV-associated Cancers
Stanford Drug Discovery Symposium, April 19, 2021
Which Stone Holds up the Bridge?
American Association of Cancer Research Virtual Annual Meeting
Margaret Foti Award for Leadership and Extraordinary Achievements in Cancer Research, April 9, 2021
Children Ask Leaders: Who are you eliminating cervical cancer for?
World Cancer Day, January 29, 2021
Preventing HPV-associated Cancers in Low- and Middle-income Countries (LMICs)
American Society for Radiation Oncology Virtual Annual Meeting, October 24-28, 2020
NCI and Cancer Research: Focused on the Future
Ohio State University Comprehensive Cancer Center Annual Scientific Meeting, October 13, 2020
Launch of SeroNet – Media Briefing
National Cancer Institute, October 8, 2020
COVID-19 Diagnostics Development
American Association for Cancer Research Virtual Meeting: COVID-19 and Cancer, July 21, 2020
AACR Distinguished Public Service Award Lecture
American Association for Cancer Research, Virtual Annual Meeting II, June 23, 2020
Final Thoughts and a Charge for the Future
NCI Childhood Cancer Data Initiative Symposium, July 31, 2019
Remarks from the NIH Hematology Oncology Fellowship Commencement
National Institutes of Health, June 21, 2019
Remarks from the National Cancer Institute Deputy Director
American Association for Cancer Research Annual Meeting, March 31, 2019
A Vaccine Against Cancer – 2017 Lasker-DeBakey Clinical Medical Research Award
Albert and Mary Lasker Foundation, September 2017
A Balanced Approach to Addressing Cancer
American Association for Cancer Research Annual Meeting, April 3, 2017
National Coalition for Cancer Research & One Voice Against Cancer Moonshot Blue Ribbon Panel Report
September 27, 2016
Seizing Today's Opportunities to Accelerate Cancer Research: An Update on the NCI Blue Ribbon Panel and a Dialogue with Early Career Investigators
American Association for Cancer Research Congressional Briefing, June 28, 2016
The HPV Vaccine: FDA Approval Was Just the Beginning
15th Annual Cancer Research Symposium on Prevention and Early Detection of Cancer, Koch Institute, MIT, June 10, 2016
Many Opportunities to Accelerate Progress in Cancer Research
American Association for Cancer Research Annual Meeting, April 18, 2016
HPV Vaccines: Recent Advances and the Potential for Further Progress
American Association for Cancer Research Annual Meeting, April 18, 2016
Understanding and Overcoming Cancer Disparities in the US and Abroad
Keynote Address, American Association for Cancer Research Health Disparities Conference, November 13, 2015
Director's Message: NCI Annual Plan & Budget Proposal for Fiscal Year 2017
September, 2015
Drastically Reducing HPV-Associated Cancers through Etiologically Based Primary and Secondary Prevention
American Association for Cancer Research Annual Meeting, April 20, 2015
Oncogenic Viruses: Past, Present, and Future.
National Academy of Sciences Annual Meeting: A Symposium on Cancer: From Basic Science to New Treatments, Prevention, and Back. April 28, 2014
Human Papillomavirus: Preventing Cancer
NIH/FAES 2014 Demystifying Medicine Series, March 25, 2014
NCI Childhood Cancer Data Initiative Symposium: Final Thoughts